Suitability of just-in-time adaptive intervention in post-COVID-19-related symptoms: A systematic scoping review
================================================================================================================
* Gerko Schaap
* Benjamin Butt
* Christina Bode
## Abstract
Patients with post-COVID-19-related symptoms require active and timely support in self-management. Just-in-time adaptive interventions (JITAI) seem promising in meeting these needs, as they aim to provide tailored interventions based on patient-centred measures. This systematic scoping review explores the suitability and examines key components of a potential JITAI in post-COVID-19 syndrome. Databases (PsycINFO, PubMed, and Scopus) were searched using terms related to post-COVID-19-related symptom clusters (fatigue and pain; respiratory problems; cognitive dysfunction; psychological problems) and to JITAI. Studies were summarised to identify potential components (interventions options, tailoring variables and decision rules), feasibility and effectiveness, and potential barriers. Out of the 341 screened records, 11 papers were included (five single-armed pilot or feasibility studies, three two-armed randomised controlled trial studies, and three observational studies). Two articles addressed fatigue or pain-related complaints, and nine addressed psychological problems. No articles about JITAI for respiratory problems or cognitive dysfunction clusters were found. Most interventions provided monitoring, education or reinforcement support, using mostly ecological momentary assessments or smartphone-based sensing. JITAIs were found to be acceptable and feasible, and seemingly effective, although evidence is limited. Given these findings, a JITAI for post-COVID-19 syndrome is promising, but needs to fit the complex, multifaceted nature of its symptoms. Future studies should assess the feasibility of machine learning to accurately predict when to execute timely interventions.
**Author Summary** Patients with post-COVID-19 syndrome (PCS) experience a lot of various, continuously fluctuating symptoms. Certain mobile health technologies, such as just-in-time adaptive intervention (JITAI), may help in dealing with these symptoms, and have been utilised in other health conditions. In this study, we investigate to what extent it would be possible to develop a JITAI for post-COVID-19 and what that would look like based on 11 existing JITAI-related articles. We found evidence for JITAI being helpful to deal with psychological problems (such as depression) and to a lesser extent with aspects of fatigue, using sensing technologies or user-reported variables. Our findings suggest that JITAI have potential to help PCS patients. However, more research is necessary to develop a JITAI to help patients deal with other symptoms (such as cognitive problems and breathing difficulties), as well as on how to predict when interventions can occur at the right time for fatigue. These findings may also be helpful to develop interventions in other disorders, such as chronic fatigue syndrome.
Keywords
* Just-in-time adaptive intervention
* Post-COVID-19 syndrome
* Scoping review
* Psychosomatic illness
* Self-management
## Introduction
COVID-19 has had an enormous lasting effect on the world since its emergence. Among those effects are the persisting sequelae COVID-19 survivors experience that are commonly referred to as long COVID, or post-COVID-19 syndrome. Post-COVID-19 syndrome is defined as “signs and symptoms that develop during or after an infection consistent with COVID-19, continue for more than 12 weeks and are not explained by an alternative diagnosis” [1]. This syndrome occurs on estimation in one in eight COVID-19 survivors [2].
Post-COVID-19-related symptoms can vary between and within post-COVID-19 patients. Over 200 different symptoms associated with different organ systems have been reported [3]. These symptoms can be summarised in various symptom clusters, as for example by (co-)occurrence and severity [4]. (1) Persistent fatigue with bodily pain are among the most commonly reported symptoms [5], and can encompass both physical and mental fatigue [6], but also post-exertional malaise (PEM) [7]. This cluster resembles psychosomatic syndromes such as chronic fatigue syndrome and fibromyalgia. (2) Respiratory problems can include (exertional) breathlessness, cough, wheezing, and chest discomfort [4]. (3) Cognitive dysfunction can include various neurological complaints, such as attention disorders, memory problems, and confusion or disorientation, sometimes referred to as brain fog [4, 5]. Besides these three clusters, (4) psychological problems including depression, anxiety, insomnia, and post-traumatic stress disorder are commonly reported [8, 9]. These symptoms clusters often co-occur in various levels of severity [10] and positively associate over time [11], requiring complex, multifaceted interventions for improvement and management.
eHealth can be promising for such interventions in post-COVID-19-related symptoms. Firstly, eHealth interventions can either support or replace traditional (face-to-face) treatments, relieving the strain on healthcare providers whilst being cost-effective. Secondly, eHealth interventions are scalable to larger target populations and have a low threshold, allowing to include patients who currently have little to no contact with healthcare providers. Thirdly, the diverse nature of post-COVID-19 syndrome necessitates multidisciplinary and tailored approaches, which eHealth interventions can provide [12]. A recent scoping review identified that eHealth interventions for post-COVID-19 syndrome already exist and preliminary evidence suggest that these are beneficial for symptom clusters such as fatigue and psychological problems [13]. However, so far, no interventions are known that support post-COVID-19 patients and intervene in real-time when they need help with their symptoms the most. Such interventions may be helpful to prevent, for example, PEM [14, 15]. Moreover, post-COVID-19 symptoms seem to be at least partly time- or context-specific [6, 11, 16], suggesting that timely support in self-management might prevent or ameliorate these complaints. One type of intervention that can account for that is Just-in-Time Adaptive Intervention (JITAI).
JITAIs are mobile health (mHealth) interventions that dynamically deliver tailored support at the right moment using real-time data [17]. For example, for supporting smoking cessation, an intervening message can get delivered when stress becomes elevated and craving increases. JITAIs can be delivered remotely and require different resources than traditional face-to-face counselling. This makes them promising for improving access to (mental) healthcare and supporting individuals in managing chronic health conditions. Despite this potential, there is currently a lack of literature on the effectiveness of JITAIs [18], especially for post-COVID-19-related symptom clusters. Furthermore, to consider the suitability of a potential post-COVID-JITAI, the key components need to be defined.
Following previous reviews [17–19], four key components of JITAI design can be specified: intervention options, tailoring variables, decision rules, and decision points. (1) Intervention options are the interventions potentially provided at a certain decision point. They can differ by type (e.g. support, information, or feedback), source (technological or human), delivery system (e.g. push message, email or phone call) and intensity, but need to fit the right contextual and temporal conditions, and hence require tailoring. (2) Adaptive tailoring variables provide such information. These variables can be collected passively (e.g. using wearables such as accelerometers or heart rate trackers, or via integrated electronic health records), actively using ecological momentary assessment (EMA; e.g. patient-reported mood or symptom levels) or both [20]. (3) Decision rules are the operationalising algorithms that specify what intervention options should be offered, under which conditions, and for whom. Simplified, these rules can be ‘IF (fatigue score ≥ [cutoff]) THEN (provide advice), IF ELSE (do nothing)’. These decision-making algorithms can be statically prespecified by researchers, i.e. based on theory or prior evidence, or dynamically computed to fit the patient, e.g. by machine learning models. These decision rules trigger at a (4) decision point, which specifies when an intervention option might be delivered. This may for example be directly after the measurement, a random prompt, or at prespecified or random time windows (e.g. every minute or twice daily).
While evidence seem to suggest that JITAIs are effective [18], it is unclear whether these advanced mHealth interventions would be suitable, feasible and effective for post-COVID-19-related symptom clusters, how such a JITAI would look like, and what would be any potential barriers (e.g. in user engagement) that need to be overcome. As decision points are informed by the other components, they are outside of this study’s scope of interest. This research could help inform decisions in the development of JITAI that can support patients with post-COVID-19-related symptoms. Thus, the objective of the current study was to scope out and identify elements of interest using the following research questions:
> *RQ1. How are JITAI components (a. interventions options, b. tailoring variables and c. decision rules) applied in JITAIs related to post-COVID-19 symptom clusters?*
> *RQ2. What can be said about the feasibility, effectiveness and potential barriers of JITAIs related to post-COVID-19 symptom clusters?*
## Methods
### Design
The systematic scoping methodological framework proposed by Arksey and O’Malley [21] was followed. The process involved: (1) identifying research questions; (2) identifying relevant studies; (3) selecting studies; (4) charting the data; and (5) collating, summarising, and reporting the results. The study is reported conforming the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist [22] (S1 PRISMA-ScR checklist). This study was registered at Open Science Framework Registries: [https://osf.io/kgecs](https://osf.io/kgecs).
### Search strategy
Three electronic databases (PubMed, Scopus and PsycINFO) were initially queried. The search terms were composed of (1) synonyms for JITAI and (2) symptom clusters, separated by Boolean operators. Specifically, the string encompassed ("JITAI" OR "Just-in-time adaptive intervention" OR "just-in-time" OR "adaptive intervention" OR “dynamic intervention”) AND ("long COVID" OR "fatigue" OR “chronic fatigue syndrome” OR "bodily pain" OR “pain” OR “myalgia” OR "cognitive problems" OR “attention disorder” OR “memory impairment” OR "respiratory problems" OR “lung disease” OR "depression" OR "anxiety" OR "insomnia"). The most recent search was performed on 5 April 2024, selecting only peer-reviewed journal articles. Afterwards, a manual snowball search through reference lists of selected studies was performed to identify other potentially relevant papers, including grey literature and book chapters. Additionally, the database ACM Digital Library was searched for relevant conference proceedings on 5 April 2024.
### Study selection
Studies were included using the following criteria: (a) addressing at least one symptom of the specified symptom clusters using JITAI; (b) available as full-text in English or German; and (c) published since January 1, 2015. Quantitative, qualitative, and mixed-method study designs were considered in the form of any type of experimental (including randomised and non-randomised controlled trials, and feasibility, pilot or usability studies) or observational setup. As the study aim was to explore JITAI component options for a potential JITAI in post-COVID-19, the studies did not necessarily have to be about evaluating JITAI specifically. Study protocols and reviews were excluded.
Studies were exported to Rayyan [23], after which duplicates were omitted. Titles and abstracts were screened against the eligibility criteria, followed by full-text evaluation, by the second author (BB). This selection was reviewed by the first and last author (GS and CB).
### Data charting and synthesis
Two authors (GS and BB) extracted data from the selected articles into tables. Information was categorised based on the research questions: type of symptom cluster, interventions options, tailoring variables, decision rules, information on effectiveness and feasibility, and discussed (potential) barriers. Additionally, author, publication year, country, type of study design, and study population were retrieved. One author (GS) synthesised the findings by deductive themes aligning with the research questions.
## Results
The initial search identified 341 studies, including 127 duplicates that were omitted. Of these 214 studies, 161 were excluded for not meeting the eligibility criteria, leaving 53 records for full-text review. Finally, 11 articles met the eligibility criteria (Fig 1). Snowball searches and searching ACM Digital Library did not result in eligible records. Included study designs varied: five single-armed feasibility or pilot studies, three two-armed randomised controlled trial (RCT) studies, and three observational studies.
[Fig 1.](http://medrxiv.org/content/early/2025/03/23/2025.03.21.25324376/F1)
Fig 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow-chart of included studies
Included study characteristics are presented in Table 1. Most (*n* = 9) studies were executed in the United States. Populations differed significantly between studies, aligning with the heterogeneous aims, varying from adolescents and adults of non-clinical populations to individuals with spinal cord injuries. A summary of JITAI key components, effectiveness, and barriers per symptom cluster is presented in Table 2. Data per study can be found in Appendix Table A1.
View this table:
[Table A1.](http://medrxiv.org/content/early/2025/03/23/2025.03.21.25324376/T3)
Table A1. JITAI key components, evaluation, and barriers of included articles
View this table:
[Table 1.](http://medrxiv.org/content/early/2025/03/23/2025.03.21.25324376/T1)
Table 1. Characteristics of included studies per post-COVID-19-related symptom cluster
View this table:
[Table 2.](http://medrxiv.org/content/early/2025/03/23/2025.03.21.25324376/T2)
Table 2. Summary of JITAI key components, evaluation, and barriers per post-COVID-19-related symptom cluster
Two articles addressed fatigue or pain-related complaints, and nine addressed psychological problems. No articles about JITAI for respiratory problems or cognitive dysfunction clusters were found.
### Fatigue and pain-related JITAI components
The included articles included two JITAIs; one focusing on pain management [35] and one on physical activity improvement [25], which might contribute to fatigue reduction.
The JITAIs provided interventions that coached participants in their self-management, namely education for pain management based on cognitive behaviour therapy (CBT) for pain [35] and reinforcing physical exercise and exercise goal attainment [25]. These interventions were initiated using static algorithms. For pain management, messages were always sent daily, but the contents were tailored using EMA of symptoms and symptom-related behaviour (e.g. pain catastrophising) with predetermined cutoff scores. For physical activity, encouraging messages were sent when moderate-to-vigorous physical activity was detected using machine learning-instigated estimations and objective measures. Daily goal attainment was checked again personalised goals. Both JITAI were found to be highly acceptable and feasible, with few, minor barriers being reported.
### Psychological problems-related JITAI components
Six of the included articles reported on five JITAIs for anxiety, disordered mood and thoughts, and sleep disturbances [26, 28, 30, 31, 33, 34], while three other articles provided useful information about JITAI components for psychological symptoms [27, 29, 32].
The majority (5 out of 6) of studies provided interventions based on CBT approaches, including (self-regulation) skill development, as well as monitoring [28, 30, 31, 33, 34]. Tailoring measurements mostly relied on EMA for mood and symptoms [26, 28, 34] or health behaviours [30, 31]. For passive measurements, one study used an accelerometer for physical activity and sleep in addition to EMA [28], while one study used smartphone sensing data of time, location (GPS and Wi-Fi), and smartphone-based social activity (e.g. texting and calling) [33]. Primarily (5 out of 6 studies), static algorithms were deployed as decision rules. Wahle et al. applied a hybrid system after an initially static algorithm, to dynamically tailor the probability of behaviour activation recommendations based on historical user data [33]. In contrast, the JITAI of Pulantara et al. required manual triggering of the intervention by clinicians [30, 31].
JITAIs were evaluated as highly feasible, acceptable and usable. Few barriers were reported, although some JITAI experienced technical issues that needed to be overcome [30], and motivation and adherence being potential limitations with EMA [26, 33] or with using wearables [28]. Preliminary effectiveness was found to be moderate to good, although all studies seemed to have been underpowered. The RCTs [26, 28, 34] observed outcomes significantly favourable for the JITAI groups, with reported effect sizes being medium to large (Cohen’s *d* between 0.5 and 0.87) [26] and large (Cohen’s *d* of 1.84 and 2.5) [34]. The non-randomised studies likewise observed significant improvements in outcomes [31, 33].
Finally, two observational studies showed how smartphone sensing data could be used to predict depressive states using machine learning models [29, 32]. Moreover, Beltzer et al. showed that the effectiveness of emotion regulation strategies against anxiety could be predicted and can be tailored to individuals [27].
## Discussion
This scoping review examined a heterogeneous set of JITAIs, targeting a variety of fatigue, pain, and psychological symptoms in various patient and non-patient populations. Interestingly, no JITAI or JITAI-related (observational) studies could be identified that targeted respiratory problems or cognitive dysfunction. Important insights into key components (a. interventions options, b. tailoring variables and c. decision rules) for a potential post-COVID-JITAI were charted, showing various applications. Additionally, JITAI and related (machine learning) algorithms seem to be generally acceptable, feasible, and effective, although evidence is limited. Few barriers were discussed in the included studies, but results indicated that stakeholder analysis (e.g. of patient and healthcare provider expectations) is important, and (minor) technical issues should be expected.
While these findings suggest promising implications for a post-COVID-JITAI, the suitability is still questionable. As seen in the included studies, as well in most JITAIs, most intervention options aim towards behaviour activation of health behaviours [18], such as encouraging to continue physical exercise. However, one major challenge is that encouraging activity and exertion can strongly backfire in many post-COVID-19 patients due to PEM – a post-COVID-19 JITAI might actually need to advise patients not to do anything at the moment to avoid PEM [3, 10]. Current rehabilitation strategies aim more towards pacing and energy management over reconditioning via (e.g.) graded exercise [36, 37]. As fatigue and PEM are among the most commonly reported and most severely experienced symptoms, they need to be appropriately addressed in a JITAI format. Help with energy management is also one of the most favoured eHealth intervention desires of post-COVID-19 patients [38]. A JITAI may partly aid in this via activity monitoring (e.g. based on physical and cognitive activity of the previous hour [16]) and feedback to provide insights in daily life exertions to help patients structure their days. Besides the fatigue cluster, studies from the psychological problems cluster show that CBT-based education and skill development may be beneficial for helping with emotion regulation. Explorative observational studies suggest that improved mood and reduced psychopathology may also lead to improved somatic post-COVID-19 symptoms [11, 39]. While intervention options need to be carefully developed, a JITAI for post-COVID-19 patients may be possible, albeit with sensible tailoring.
Tailoring variables of the selected JITAIs used both EMA and passive, objective measures. Multiple included studies showed that smartphone-based sensing data of physical and social activities provide good proxy measures for psychopathologies, and that accelerometers can help with physical activity tracking. Somatic symptoms – especially those without proxies or (accessible) biomarkers – still may require EMA. In particular fatigue tailoring is challenging given its complex, multifaceted, subjective and fluctuating nature [40]. As both false positives and false negatives (or over- and underestimation) of severe fatigue can lead to the wrong triggering decision, accurate identification is crucial. Schneider et al. [41] argue for an adaptive assessment via fatigue questionnaire items that dynamically tailor (“by individual and time of day”) the cutoff scores with fewer EMA questions [41](p770). Furthermore, not only can artificial intelligence models help improve the understanding of fatigue in general [40], machine learning can be leveraged to also incorporate wearable biosensors, resulting in more accurate, multimodal predictions [42]. For example, individually tailored fatigue EMA may be supplemented with skin conduction measurements. A post-COVID-JITAI should also be able to tailor interventions to multiple, potentially interrelated symptoms (e.g. depressed mood and breathlessness), signals (e.g. skin conduction and heart rate), and behavioural and environmental factors (e.g. activity, background noise, and light intensity). The feasibility of these complex predictions should be tested first similar to the observational studies included in our findings [27, 29, 32].
Similarly, future steps are needed to develop reliable, dynamic decision rules based on these symptoms and signals. Most of the included studies featured static, partially automated systems, which is common for JITAI. However, full automation requires less work for users and healthcare providers [43]. Only after identifying the correct, accurate predictors can these decision rules be designed.
Interestingly, no JITAIs for the cognitive dysfunction and respiratory problems clusters were found. While specific interventions for cognitive dysfunction (e.g. disorientation) may not be necessary, a post-COVID-JITAI should be able to account for these states. For respiratory problems, mHealth interventions for pulmonary rehabilitation exists, such as providing breathing techniques [44]. While it may not be necessary to trigger these ‘just-in-time’, they can be incorporated into a post-COVID-JITAI for those with respiratory problems as, for example, a daily exercise as well as monitoring. That way, post-COVID-19 patients can have a single system aiding in symptom management [38].
While the feasibility and acceptability should be studied further, JITAIs are (relatively) easily embraced by patients. Minor barriers point towards careful investigations with stakeholders (patients and healthcare providers), but they seem to fit well with participants’ expectations. Nevertheless, the evidence for effectiveness requires more research in larger samples, as is common for JITAI RCTs [18].
This study encompasses a scoping overview of JITAIs for illnesses with post-COVID-19-related symptoms using a rigorous methodology [21]. The findings should however be interpreted with caution. The search query was relatively simple and could have been optimised by expanding on the included symptom-related terms. Snowball searching for related JITAIs was executed to make up for this. On a related note, there currently is no consensus on definitions of JITAI. While the query included multiple possible related terms, others could have been missed. Ecological momentary interventions were excluded from the query due to the scope and time, but might also have been insightful as non-automated or partially automated intervention systems. Simarly, while over 100 different post-COVID-19 symptoms can be defined [3], by choice the scope of this study was on the most commonly reported, potentially fluctuating symptoms. This may not align with the needs and preferences of patients [38], necessitating follow-up studies.
## Conclusion
The aim of this scoping review was to explore the suitability of a JITAI for post-COVID-19 syndrome. Based on JITAIs for post-COVID-19-related symptoms key components were discussed, and found to be promising, but many questions remain. A post-COVID-JITAI could help handle the fluctuating nature of symptoms and support in the various difficulties in self-management. Future studies should look into the feasibility of machine learning to accurately predict symptom severity in complex, multifaceted and interrelated mess of post-COVID-19 syndrome to trigger psychoeducation, cognitive behaviour therapy and monitoring and early warnings for post-exertional malaise. This information may also benefit timely interventions in other complex (psycho)somatic disorders such as fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome.
## Data Availability
N/A (however, data from studies included in this systematic scoping review is included as an appendix)
## Acknowledgements
Not applicable
* Received March 21, 2025.
* Revision received March 21, 2025.
* Accepted March 23, 2025.
* © 2025, Posted by Cold Spring Harbor Laboratory
This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/)
## References
1. [1].National Institute for Health and Care Excellence. COVID-19 Rapid Guideline: Managing the long-term effects of COVID-19, [https://www.nice.org.uk/guidance/ng188](https://www.nice.org.uk/guidance/ng188); 2021 [accessed 22 May 2023 2023].
2. [2].Ballering AV, van Zon SKR, olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452–61. doi:10.1016/S0140-6736(22)01214-4.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(22)01214-4&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=35934007&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
3. [3].Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133–46. doi:10.1038/s41579-022-00846-2.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/s41579-022-00846-2&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=36639608&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
4. [4].Global Burden of Disease Long COVID Collaborators. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604–15. doi:10.1001/jama.2022.18931.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jama.2022.18931&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=36215063&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
5. [5].Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi:10.1038/s41598-021-95565-8.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/s41598-021-95565-8&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=34373540&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
6. [6].Wensink M, Schaap G, ten Klooster PM, Doggen CJM, van der Palen J, Vonkeman HE, et al. Physical and mental fatigue in post-COVID syndrome and their associations over time: A small-sample ESM-study to explore fatigue, quality of sleep and behaviours. J Psychosom Res. 2023;164:111084. doi:10.1016/j.jpsychores.2022.111084.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jpsychores.2022.111084&link_type=DOI)
7. [7].Appelman B, Charlton BT, Goulding RP, Kerkhoff TJ, Breedveld EA, Noort W, et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat Commun. 2024;15(1):17. doi:10.1038/s41467-023-44432-3.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/s41467-023-44432-3&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=38177128&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
8. [8].Dorri M, Mozafari Bazargany MH, Khodaparast Z, Bahrami S, Seifi Alan M, Rahimi F, et al. Psychological problems and reduced health-related quality of life in the COVID-19 survivors. J Affect Disord Rep. 2021;6:100248. doi:10.1016/j.jadr.2021.100248.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jadr.2021.100248&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=34642678&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
9. [9].Kyzar EJ, Purpura LJ, Shah J, Cantos A, Nordvig AS, Yin MT. Anxiety, depression, insomnia, and trauma-related symptoms following COVID-19 infection at long-term follow-up. Brain Behav Immun Health. 2021;16:100315. doi:10.1016/j.bbih.2021.100315.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.bbih.2021.100315&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=34345869&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
10. [10].Greenhalgh T, Sivan M, Perlowski A, Nikolich JŽ. Long COVID: A clinical update. Lancet. 2024;404(10453):707–24. doi:10.1016/S0140-6736(24)01136-X.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/S0140-6736(24)01136-X&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=39096925&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
11. [11].Schaap G, Wensink M, Doggen CJM, van der Palen J, Vonkeman HE, Bode C. Affect and post-COVID-19 symptoms in daily life: An exploratory experience sampling study. PLoS ONE. 2024;19(10):e0295217. doi:10.1371/journal.pone.0295217.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pone.0295217&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=39446922&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
12. [12].Greenhalgh T, Wherton J, Papoutsi C, Lynch J, Hughes G, A’Court C, et al. Beyond adoption: A new framework for theorizing and evaluating nonadoption, abandonment, and challenges to the scale-up, spread, and sustainability of health and care technologies. J Med Internet Res. 2017;19(11):e367. doi:10.2196/jmir.8775.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=doi:10.2196/jmir.8775&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=29092808&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
13. [13].Rinn R, Gao L, Schoeneich S, Dahmen A, Anand Kumar V, Becker P, et al. Digital interventions for treating post-COVID or long-COVID symptoms: Scoping review. J Med Internet Res. 2023;25:e45711. doi:10.2196/45711.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2196/45711&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=36943909&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
14. [14].Tanguay P, Gaboury I, Daigle F, Bhéreur A, Dubois O, Lagueux É, et al. Post-exertional malaise may persist in Long COVID despite learning STOP-REST-PACE. Fatigue Biomed Health Beh. 2023:1–16. doi:10.1080/21641846.2023.2222199.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/21641846.2023.2222199&link_type=DOI)
15. [15].Twomey R, DeMars J, Franklin K, Culos-Reed SN, Weatherald J, Wrightson JG. Chronic fatigue and postexertional malaise in people living with long COVID: An observational study. Phys Ther. 2022. doi:10.1093/ptj/pzac005.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/ptj/pzac005&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=35079817&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
16. [16].Greenwood DC, Mansoubi M, Bakerly ND, Bhatia A, Collett J, Davies HE, et al. Physical, cognitive, and social triggers of symptom fluctuations in people living with long COVID: an intensive longitudinal cohort study. Lancet Reg Health Eur. 2024;46. doi:10.1016/j.lanepe.2024.101082.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.lanepe.2024.101082&link_type=DOI)
17. [17].Nahum-Shani I, Smith SN, Spring BJ, Collins LM, Witkiewitz K, Tewari A, et al. Just-in-time adaptive interventions (JITAIs) in mobile health: Key components and design principles for ongoing health behavior support. Ann Behav Med. 2017;52(6):446–62. doi:10.1007/s12160-016-9830-8.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s12160-016-9830-8&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=27663578&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
18. [18].Wang L, Miller LC. Just-in-the-moment adaptive interventions (JITAI): A meta-analytical review. Health Commun. 2020;35(12):1531–44. doi:10.1080/10410236.2019.1652388.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/10410236.2019.1652388&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=31488002&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
19. [19].Coppersmith DDL, Dempsey W, Kleiman EM, Bentley KH, Murphy SA, Nock MK. Just-in-time adaptive interventions for suicide prevention: Promise, challenges, and future directions. Psychiatry. 2022;85(4):317–33. doi:10.1080/00332747.2022.2092828.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/00332747.2022.2092828&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=35848800&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
20. [20].Klasnja P, Hekler EB, Shiffman S, Boruvka A, Almirall D, Tewari A, et al. Microrandomized trials: An experimental design for developing just-in-time adaptive interventions. Health Psychol. 2015;34(12):1220–8. doi:10.1037/hea0000305.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1037/hea0000305&link_type=DOI)
21. [21].Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32. doi:10.1080/1364557032000119616.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1080/1364557032000119616&link_type=DOI)
22. [22].Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018;169(7):467–73. doi:10.7326/M18-0850.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.7326/M18-0850&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=30178033&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
23. [23].Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi:10.1186/s13643-016-0384-4.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s13643-016-0384-4&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=27919275&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
24. [24].Azizoddin DR, DeForge SM, Baltazar A, Edwards RR, Allsop M, Tulsky JA, et al. Development and pre-pilot testing of STAMP + CBT: an mHealth app combining pain cognitive behavioral therapy and opioid support for patients with advanced cancer and pain. Supportive Care in Cancer. 2024;32(2):123. doi:10.1007/s00520-024-08307-7.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s00520-024-08307-7&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=38252172&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
25. [25].Hiremath SV, Amiri AM, Thapa-Chhetry B, Snethen G, Schmidt-Read M, Ramos-Lamboy M, et al. Mobile health-based physical activity intervention for individuals with spinal cord injury in the community: A pilot study. PLoS ONE. 2019;14(10):e0223762. doi:10.1371/journal.pone.0223762.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pone.0223762&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=31613909&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
26. [26].Bell I, Arnold C, Gilbertson T, D’Alfonso S, Castagnini E, Chen N, et al. A personalized, transdiagnostic smartphone intervention (Mello) targeting repetitive negative thinking in young people with depression and anxiety: Pilot randomized controlled trial. J Med Internet Res. 2023;25:e47860. doi:10.2196/47860.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2196/47860&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=38090786&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
27. [27].Beltzer ML, Ameko MK, Daniel KE, Daros AR, Boukhechba M, Barnes LE, et al. Building an emotion regulation recommender algorithm for socially anxious individuals using contextual bandits. Br J Clin Psychol. 2022;61(S1):51–72. doi:10.1111/bjc.12282.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/bjc.12282&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=33583059&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
28. [28].Carlozzi NE, Choi SW, Wu Z, Troost JP, Lyden AK, Miner JA, et al. An app-based just-in-time-adaptive self-management intervention for care partners: The CareQOL feasibility pilot study. Rehabil Psychol. 2022;67(4):497–512. doi:10.1037/rep0000472.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1037/rep0000472&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=36355640&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
29. [29].Jacobson NC, Chung YJ. Passive sensing of prediction of moment-to-moment depressed mood among undergraduates with clinical levels of depression sample using smartphones. Sens. 2020;20(12):3572. doi:10.3390/s20123572.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/s20123572&link_type=DOI)
30. [30].Pulantara IW, Parmanto B, Germain A. Development of a just-in-time adaptive mHealth intervention for insomnia: Usability study. JMIR Hum Factors. 2018;5(2):e21. doi:10.2196/humanfactors.8905.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2196/humanfactors.8905&link_type=DOI)
31. [31].Pulantara IW, Parmanto B, Germain A. Clinical feasibility of a just-in-time adaptive intervention app (iREST) as a behavioral sleep treatment in a military population: Feasibility comparative effectiveness study. J Med Internet Res. 2018;20(12):e10124. doi:10.2196/10124.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2196/10124&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=30530452&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
32. [32].Ren B, Balkind EG, Pastro B, Israel ES, Pizzagalli DA, Rahimi-Eichi H, et al. Predicting states of elevated negative affect in adolescents from smartphone sensors: a novel personalized machine learning approach. Psychol Med. 2023;53(11):5146–54. doi:10.1017/S0033291722002161.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1017/S0033291722002161&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=35894246&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
33. [33].Wahle F, Kowatsch T, Fleisch E, Rufer M, Weidt S. Mobile sensing and support for people with depression: A pilot trial in the wild. JMIR Mhealth Uhealth. 2016;4(3):e111. doi:10.2196/mhealth.5960.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2196/mhealth.5960&link_type=DOI)
34. [34].Wang L, Miller L. Assessment and disruption of ruminative episodes to enhance mobile cognitive behavioral therapy just-in-time adaptive interventions in clinical depression: Pilot randomized controlled trial. JMIR Form Res. 2023;7:e37270. doi:10.2196/37270.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2196/37270&link_type=DOI)
35. [35].Azizoddin DR, DeForge SM, Baltazar A, Edwards RR, Allsop M, Tulsky JA, et al. Development and pre-pilot testing of STAMP + CBT: an mHealth app combining pain cognitive behavioral therapy and opioid support for patients with advanced cancer and pain. Support Care Cancer. 2024;32(2). doi:10.1007/s00520-024-08307-7.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s00520-024-08307-7&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=38252172&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
36. [36].Ghali A, Lacombe V, Ravaiau C, Delattre E, Ghali M, Urbanski G, et al. The relevance of pacing strategies in managing symptoms of post-COVID-19 syndrome. J Transl Med. 2023;21(1):375. doi:10.1186/s12967-023-04229-w.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1186/s12967-023-04229-w&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=37291581&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
37. [37].Ladlow P, Bennett AN, O’Sullivan O. Exercise therapy for post–COVID-19 condition— Does no harm. JAMA Netw Open. 2024;7(4):e246959-e. doi:10.1001/jamanetworkopen.2024.6959.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jamanetworkopen.2024.6959&link_type=DOI)
38. [38].Schröder J, Dinse H, Jahre LM, Skoda E-M, Stettner M, Kleinschnitz C, et al. Needs and demands for e-Health symptom management interventions in patients with post-COVID-19 condition: A user-centered design approach. Telemed e-Health. 2024;30(8). doi:10.1089/tmj.2024.0088.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1089/tmj.2024.0088&link_type=DOI)
39. [39].Milde C, Glombiewski JA, Wilhelm M, Schemer L. Psychological factors predict higher odds and impairment of post-COVID symptoms: A prospective study. Psychosom Med. 2023;85(6):479–87. doi:10.1097/psy.0000000000001214.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1097/psy.0000000000001214&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=37199433&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
40. [40].Rudroff T. Revealing the complexity of fatigue: A review of the persistent challenges and promises of artificial intelligence. Brain Sci. 2024;14(2):186. doi:10.3390/brainsci14020186
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/brainsci14020186&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=38391760&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
41. [41].Schneider S, Junghaenel DU, Smyth JM, Fred Wen CK, Stone AA. Just-in-time adaptive ecological momentary assessment (JITA-EMA). Behav Res Method. 2024;56:765–83. doi:10.3758/s13428-023-02083-8.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3758/s13428-023-02083-8&link_type=DOI)
42. [42].Hooda R, Joshi V, Shah M. A comprehensive review of approaches to detect fatigue using machine learning techniques. Chron Dis Transl Med. 2022;8(1):26–35. doi:10.1016/j.cdtm.2021.07.002.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.cdtm.2021.07.002&link_type=DOI)
43. [43].Oikonomidi T, Ravaud P, LeBeau J, Tran V-T. A systematic scoping review of just-in-time, adaptive interventions finds limited automation and incomplete reporting. J Clin Epidemiol. 2023;154:108–16. doi:10.1016/j.jclinepi.2022.12.006.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jclinepi.2022.12.006&link_type=DOI)
[PubMed](http://medrxiv.org/lookup/external-ref?access_num=36521653&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2025%2F03%2F23%2F2025.03.21.25324376.atom)
44. [44].Daniels K, Mourad J, Bonnechère B. Exploring the use of mobile health for the rehabilitation of long COVID patients: A scoping review. Healthc. 2024;12(4):451. doi:10.3390/healthcare12040451.
[CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3390/healthcare12040451&link_type=DOI)